MJMengping Jia

Mengping Jia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mengping Jia has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Cong Niu

    Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China

    1 shared publication
  • Dan Meng

    Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Zhongshan Hospital, Fudan University, Shanghai, China

    1 shared publication
  • Jieyu Guo

    Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Zhongshan Hospital, Fudan University, Shanghai, China

    1 shared publication
  • Qinhan Li

    Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Department of Rheumatology, Zhongshan Hospital Immunotherapy Translational Research Center, Fudan University, Shanghai, China. (Y. Hou, Q. Li, X.L., J.G., Q.P., Y.L., Y. He, J.J., X. Wei, J.L., S.M., N.J., J.M., X.Z., Q.J., Q. Liang, L.J., X. Wang, D.M.)

    1 shared publication
  • Xiangxiang Wei

    Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China

    1 shared publication
  • Xinyue Zhang

    Institute of Neuroscience, Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Bach1: Function, Regulation, and Involvement in Disease

    by Xinyue Zhang, Jieyu Guo, Xiangxiang Wei, Cong Niu, Mengping Jia, Qinhan Li, Dan Meng

    The transcription factor BTB and CNC homology 1 (Bach1) is widely expressed in most mammalian tissues and functions primarily as a transcriptional suppressor by heterodimerizing with small Maf proteins and binding to Maf recognition elements in the promoters of targeted genes. It has a key regulatory role in the production of reactive oxygen species, cell cycle, heme homeostasis, hematopoiesis, and immunity and has been shown to suppress ischemic angiogenesis and promote breast cancer metastasis. This review summarizes how Bach1 controls these and other cellular and physiological and pathological processes. Bach1 expression and function differ between different cell types. Thus, therapies designed to manipulate Bach1 expression will need to be tightly controlled and tailored for each specific disease state or cell type.